CD274 and neoplasm: A recent study revealed that MYC inhibitor not only suppressed tumor growth in mice, but also increased T cell immune infiltration, enhanced PD-L1 expression on tumors, and increased tumor sensitivity to anti-PD1 immunotherapy (45).